Asset Details
Do you wish to reserve the book?
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
Do you wish to request the book?
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
2013
Overview
Background
Breast cancer is a potentially fatal malignancy in females despite the improvement in therapeutic techniques. The identification of novel molecular signatures is needed for earlier detection, monitoring effects of treatment, and predicting prognosis. We have previously used microarray analysis to identify differentially expressed genes in aggressive breast tumors. The purpose of the present study was to investigate the prognostic value of the candidate biomarkers
CCNB2
,
ASPM
,
CDCA7
,
KIAA0101,
and
SLC27A2
in breast cancer.
Methods
The expression levels and subcellular localization of the CCNB2, ASPM, CDCA7, KIAA0101, and SLC27A2 proteins were measured using immunohistochemistry (IHC) on a panel of 80 primary invasive breast tumors. Furthermore, the mRNA levels of
CCNB2
,
KIAA0101,
and
SLC27A2
were subsequently examined by qRT-PCR to validate IHC results. Patient disease-specific survival (DSS) was evaluated in correlation to protein levels using the Kaplan-Meier method. Multivariate Cox regression analysis was used to determine the impact of aberrant protein expression of the candidate biomarkers on patient DSS and to estimate the hazard ratio at 8-year follow-up.
Results
Elevated cytoplasmic CCNB2 protein levels were strongly associated with short-term disease-specific survival of breast cancer patients (≤ 8 years;
P
<0.001) and with histological tumor type (
P
= 0.04). However, no association with other clinicopathological parameters was observed. Multivariate Cox regression analysis specified that CCNB2 protein expression is an independent prognostic marker of DSS in breast cancer. The predictive ability of several classical clinicopathological parameters was improved when used in conjunction with CCNB2 protein expression (C-index = 0.795) in comparison with a model without CCNB2 expression (C-index = 0.698). The protein levels of ASPM, CDCA7, KIAA0101, and SLC27A2 did not correlate with any clinicopathological parameter and had no influence on DSS. However, a significant correlation between the expression of the CCNB2 and ASPM proteins was detected (
P
= 0.03).
Conclusion
These findings suggest that cytoplasmic CCNB2 may function as an oncogene and could serve as a potential biomarker of unfavorable prognosis over short-term follow-up in breast cancer.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Aged
/ Biomarkers, Tumor - analysis
/ Biomarkers, Tumor - genetics
/ Biomedical and Life Sciences
/ Breast Neoplasms - chemistry
/ Breast Neoplasms - mortality
/ Breast Neoplasms - pathology
/ Cancer
/ Carcinoma, Ductal, Breast - chemistry
/ Carcinoma, Ductal, Breast - genetics
/ Carcinoma, Ductal, Breast - mortality
/ Carcinoma, Ductal, Breast - pathology
/ Carcinoma, Ductal, Breast - therapy
/ Carcinoma, Lobular - chemistry
/ Carcinoma, Lobular - genetics
/ Carcinoma, Lobular - mortality
/ Carcinoma, Lobular - pathology
/ Carcinoma, Lobular - therapy
/ CCNB2
/ Female
/ Health Promotion and Disease Prevention
/ Humans
/ In Situ Hybridization, Fluorescence
/ Medicinska och farmaceutiska grundvetenskaper
/ Oncology
/ Proteins
/ Real-Time Polymerase Chain Reaction
/ RNA
/ Tumors
